✦ LIBER ✦

Infliximab acts directly on human osteoclast precursors and enhances osteoclast formation induced by receptor activator of nuclear factor κB ligand in vitro

✍ Scribed by Chikahiro Takita; Yosuke Fujikawa; Ichiro Itonaga; Hirofumi Taira; Masayuki Kawashima; Takehiko Torisu

Publisher: Springer
Year: 2005
Tongue: English
Weight: 372 KB
Volume: 15
Category: Article
ISSN: 1439-7595
DOI: 10.1007/s10165-004-0373-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro blockade of receptor activator

In vitro blockade of receptor activator of nuclear factor-κB ligand prevents osteoclastogenesis induced by neuroblastoma cells

✍ Donatella Granchi; Ilaria Amato; Luca Battistelli; Sofia Avnet; Sergio Capacciol 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 550 KB

## Abstract Proliferation and differentiation of osteoclasts are regulated by a cytokine system that includes RANKL, which binds 2 receptors: RANK, which activates osteoclast differentiation, and osteoprotegerin (OPG), a decoy receptor that limits RANKL action. We investigated the role of the OPG/R

CD40-CD40 ligand interactions in human m

CD40-CD40 ligand interactions in human microglia induce CXCL8 (interleukin-8) secretion by a mechanism dependent on activation of ERK1/2 and nuclear translocation of nuclear factor-κB (NFκB) and activator protein-1 (AP-1)

✍ Teresa G. D'Aversa; Eliseo A. Eugenin; Joan W. Berman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 971 KB

## Abstract CXCL8 is a CXC chemokine that recruits leukocytes to sites of inflammation. Expression of CXCL8 in the CNS has been demonstrated in neuroinflammatory diseases, including human immunodeficiency virus (HIV‐1) encephalitis, but the mechanism of secretion of this chemokine is not fully unde